1. As semaglutide drug patent expires, what to know about weight loss drug availability  The Indian Express
  2. Ozempic, Wegovy: India’s cheap weight-loss drugs could reshape global obesity fight  BBC
  3. Ozempic Is About to Go Generic in India, China and Canada  The New York Times
  4. Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India  Reuters
  5. India’s weight-loss drug sales are projected to soar to over half a billion by 2030  themercury.com